High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer

PURPOSE: High-dose-rate (HDR) brachytherapy has been accepted as an effective and safe method to treat prostate cancer. The aim of this study was to describe acute toxicity following HDR brachytherapy to the prostate, and to examine the association between dosimetric parameters and urinary toxicity...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Contemp Brachytherapy
Main Authors: Cendales, Ricardo, Alwers, Elizabeth, Cifuentes, Javier, Bobadilla, Ivan, Torres, Felipe, Arbelaez, Juan, Gaitan, Armando, Cortes, Helber, Acevedo, Yenny, Quintero, Paulo, Vasquez, Jaider
Format: Artigo
Jezik:Inglês
Izdano: Termedia Publishing House 2015
Teme:
Original Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4371062/
https://ncbi.nlm.nih.gov/pubmed/25829931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2015.48838
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki